Company Name, Ticker, Industry, else..

Avanos Medical Inc (AVNS)

Other Ticker:

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Avanos Medical Inc

AVNS's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

AVNS Growth rates comparisons

Looking into Avanos Medical Inc growth rates, revenue grew by 12.46 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1779

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -4.45 %

Avanos Medical Inc realized net income compared to net loss a year ago in IV. Quarter 2022

• More on AVNS's Growth

AVNS's Valuation comparisons

Avanos Medical Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Avanos Medical Inc PEG ratio is at 0.03 Company is currently trading with Price to Cash flow multiple of 148.36 in trailing twelve-month period.

Company

26.76

PE TTM

Industry

-

PE TTM

Company's Price to Sales ratio is at 1.66.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.53.

• More on AVNS's Valuation

Total Debt (Millions $)	233
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	5.28
Tangible Book Value (Per Share $)	4.68

AVNS's Valuation comparisons

Avanos Medical Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Avanos Medical Inc PEG ratio is at 0.03 Company is currently trading with Price to Cash flow multiple of 148.36 in trailing twelve-month period.

Company

26.76

PE TTM

Industry

-

PE TTM

Company's Price to Sales ratio is at 1.66.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.53.

Avanos Medical Inc Price to Book Ratio is at 1.06 higher than Indusry Avg. of -0.02, and higher than S&P 500 Avg. of -0.01

• More on AVNS's Valuation

• Market Capitalization (Millions $)	1,365
• Shares Outstanding (Millions)	47
• Employees	-
• Revenues (TTM) (Millions $)	820
• Net Income (TTM) (Millions $)	51
• Cash Flow (TTM) (Millions $)	9
• Capital Exp. (TTM) (Millions $)	-19
• Total Debt (Millions $)	233
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	5.28
• Tangible Book Value (Per Share $)	4.68

• Market Capitalization (Millions $)	1,365
• Shares Outstanding (Millions)	47
• Employees	-
• Revenues (TTM) (Millions $)	820
• Net Income (TTM) (Millions $)	51
• Cash Flow (TTM) (Millions $)	9
• Capital Exp. (TTM) (Millions $)	-19

AVNS's Profitability Comparisons
Avanos Medical Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 12.46 % from 9.25 % in III. Quarter. Avanos Medical Inc net profit margin of 8.09 % is currently ranking no. 28 in Biotechnology & Pharmaceuticals industry, ranking no. 125 in Healthcare sector and number 1423 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	2.89
• Total Debt to Equity (MRQ)	0.18
• Tangible Leverage Ratio (MRQ)	2.19
• Asset Turnover Ratio (TTM)	0.46
• Inventory Turnover Ratio (TTM)	2.08

AVNS's Profitability Comparisons

Avanos Medical Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 12.46 % from 9.25 % in III. Quarter.

Avanos Medical Inc net profit margin of 8.09 % is currently ranking no. 28 in Biotechnology & Pharmaceuticals industry, ranking no. 125 in Healthcare sector and number 1423 in S&P 500.

• More on AVNS's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar GATO's Profile Stock Price GATO's Financials Business Description Fundamentals Charts & Quotes GATO's News Suppliers GATO's Competitors Customers & Markets Economic Indicators GATO's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071